This Article Full Text Full Text (PDF) All Versions of this Article: 92/3/834    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hauffa, B. P. Articles by Petersenn, S. Search for Related Content PubMed PubMed Citation Articles by Hauffa, B. P. Articles by Petersenn, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Genetics Home Reference Medline Plus Health Information Nutrition Prader-Willi Syndrome Related Collections Metabolism Obesity Neuroendocrinology and Pituitary Pediatric Endocrinology

The Effect of Growth Hormone on the Response of Total and Acylated Ghrelin to a Standardized Oral Glucose Load and Insulin Resistance in Children with Prader-Willi Syndrome

Department of Pediatric Hematology/Oncology and Endocrinology, University Children’s Hospital (B.P.H., K.H.), and Department of Endocrinology, University Medical Center (I.M.R., N.U., K.M., S.P.), University of Duisburg-Essen, D-45122 Essen, Germany

Address all correspondence and requests for reprints to: Berthold P. Hauffa, M.D., Ph.D., Department of Pediatric Hematology/Oncology and Endocrinology, University Children’s Hospital, Hufelandstrasse 55, D-45122 Essen, Germany. E-mail: berthold.hauffa{at}uni-essen.de.

Context: Fasting levels of plasma ghrelins are grossly elevated in children with Prader-Willi syndrome (PWS). The cause of this elevation and the regulation of ghrelins in PWS is largely unknown. The regulatory role of individual nutritional components and of GH is not well characterized.

Objective: We investigated the influence of GH on acylated (aGhr) and total ghrelin (tGhr) concentrations before and after an oral glucose load, and on insulin resistance in PWS children.

Design, Patients, and Interventions: In a clinical follow-up study, plasma ghrelins were measured during an oral glucose tolerance test, and parameters of insulin resistance were determined in 28 PWS children before and/or 1.18 (0.42–9.6) yr (median, range) after start of GH therapy (0.035 mg/kg body weight per day).

Main Outcome Measures: Fasting and postglucose concentrations of aGhr and tGhr and homeostasis model assessment 2 insulin resistance were the main outcome measures.

Setting: The study was conducted in a single center (University Children’s Hospital).

Results: High fasting [1060 ± 292 (SD) pg/ml; n = 12] and postglucose trough (801 ± 303 pg/ml; n = 10) tGhr concentrations in GH-untreated PWS children were found to be decreased in the GH-treated group (fasting 761 ± 247 pg/ml, n = 24, P = 0.006; postglucose 500 ± 176 pg/ml, n = 20; P = 0.006). In contrast, aGhr concentrations and insulin resistance were not changed by GH treatment. Both aGhr and tGhr concentrations were decreased by oral carbohydrate administration, independent of the GH treatment status.

Conclusions: Our results indicate that, in PWS children, aGhr and tGhr are differentially regulated by GH.

This article has been cited by other articles:

				E. Feigerlova, G. Diene, F. Conte-Auriol, C. Molinas, I. Gennero, J.-P. Salles, C. Arnaud, and M. Tauber Hyperghrelinemia Precedes Obesity in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2800 - 2805. [Abstract] [Full Text] [PDF]